183 related articles for article (PubMed ID: 2331853)
1. Activity of cephalosporins against coagulase-negative staphylococci.
Chin NX; Neu NM; Neu HC
Diagn Microbiol Infect Dis; 1990; 13(1):67-9. PubMed ID: 2331853
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
Mordenti JJ; Davis RH; Lammel CJ; Brooks GF
Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
[TBL] [Abstract][Full Text] [Related]
3. Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Stratton CW; Liu C; Weeks LS
Antimicrob Agents Chemother; 1987 Aug; 31(8):1210-5. PubMed ID: 2820300
[TBL] [Abstract][Full Text] [Related]
4. Inoculum effect on growth-delay time of oxacillin-resistant strains of Staphylococcus aureus and Staphylococcus epidermidis exposed to cefamandole, cefazolin, and cefuroxime.
Yourassowsky E; van der Linden MP; Crokaert F
Antimicrob Agents Chemother; 1990 Apr; 34(4):505-9. PubMed ID: 2344158
[TBL] [Abstract][Full Text] [Related]
5. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
Menzies RE; Cornere BM; MacCulloch D
Antimicrob Agents Chemother; 1987 Jan; 31(1):42-5. PubMed ID: 3646002
[TBL] [Abstract][Full Text] [Related]
6. Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype.
Woods GL; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1987 Sep; 31(9):1332-7. PubMed ID: 3674845
[TBL] [Abstract][Full Text] [Related]
7. Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
Hansen-Nord M; Gahrn-Hansen B; Siboni K
APMIS; 1988 Feb; 96(2):133-40. PubMed ID: 3345258
[TBL] [Abstract][Full Text] [Related]
8. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Nodzo SR; Boyle KK; Frisch NB
J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
[TBL] [Abstract][Full Text] [Related]
9. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
Siebert WT; Moreland N; Williams TW
J Infect Dis; 1979 Apr; 139(4):452-7. PubMed ID: 438546
[TBL] [Abstract][Full Text] [Related]
10. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
Wiktorowicz-Belzyt E; Wojak I; Janicka G
Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cefazolin, cefamandole, vancomycin, and LY146032 for prophylaxis of experimental Staphylococcus epidermidis endocarditis.
Wheat LJ; Smith JW; Reynolds J; Bemis AT; Treger T; Norton JA
Antimicrob Agents Chemother; 1988 Jan; 32(1):63-7. PubMed ID: 2831815
[TBL] [Abstract][Full Text] [Related]
12. Characterization of resistance phenotype and cephalosporin activity in oxacillin-resistant Staphylococcus aureus.
Mateos-Mora M; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1988 Feb; 32(2):170-4. PubMed ID: 3364941
[TBL] [Abstract][Full Text] [Related]
13. Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of beta-lactamase.
John JF; McNeill WF
Antimicrob Agents Chemother; 1980 Feb; 17(2):179-83. PubMed ID: 6966906
[TBL] [Abstract][Full Text] [Related]
14. Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents.
Rolston KV; Thirolf P; Ho DS; Bodey GP
J Antimicrob Chemother; 1985 Nov; 16(5):659-62. PubMed ID: 3852834
[TBL] [Abstract][Full Text] [Related]
15. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
Frongillo RF; Bianchi P; Moretti A; Pasticci MB; Ripa S; Pauluzzi S
Antimicrob Agents Chemother; 1984 May; 25(5):666-8. PubMed ID: 6563877
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactam susceptibility of coagulase-negative staphylococci causing catheter sepsis in pediatric patients.
Marcon MJ; Nahata MC; Powell DA; Lisby-Sutch SM
Diagn Microbiol Infect Dis; 1990; 13(1):9-15. PubMed ID: 2331855
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Garcia R; Raad I
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):933-6. PubMed ID: 9031876
[TBL] [Abstract][Full Text] [Related]
19. [Resistance of methicillin-resistant staphylococci to new cephalosporin antibiotics (author's transl)].
Kayser FH
Infection; 1980; 8(4):165-70. PubMed ID: 7298199
[TBL] [Abstract][Full Text] [Related]
20. Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci.
Smith JA; Henry DA; Bourgault AM; Bryan L; Harding GJ; Hoban DJ; Horsman GB; Marrie T; Turgeon P
J Clin Microbiol; 1987 Sep; 25(9):1741-6. PubMed ID: 3654944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
